Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 AUD | -1.23% | -4.76% | -44.83% |
Apr. 30 | ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8% | MT |
Apr. 30 | Transcript : ImpediMed Limited, Q3 2024 Earnings Call, Apr 30, 2024 |
Sales 2024 * | 10.85M 7.15M | Sales 2025 * | 19.15M 12.62M | Capitalization | 162M 107M |
---|---|---|---|---|---|
Net income 2024 * | -21M -13.84M | Net income 2025 * | -14M -9.22M | EV / Sales 2024 * | 12.7 x |
Net cash position 2024 * | 24.42M 16.09M | Net cash position 2025 * | 13.15M 8.66M | EV / Sales 2025 * | 7.76 x |
P/E ratio 2024 * |
-8.09
x | P/E ratio 2025 * |
-12.6
x | Employees | 76 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.74% |
Latest transcript on ImpediMed Limited
1 day | -1.23% | ||
1 week | -4.76% | ||
Current month | -4.76% | ||
1 month | -13.98% | ||
3 months | -13.04% | ||
6 months | -38.46% | ||
Current year | -44.83% |
Managers | Title | Age | Since |
---|---|---|---|
Parmjot Bains
CEO | Chief Executive Officer | - | Jan. 07 |
McGregor Grant
DFI | Director of Finance/CFO | - | 23-09-27 |
Steven Chen
CTO | Chief Tech/Sci/R&D Officer | - | 23-09-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Parmjot Bains
CEO | Chief Executive Officer | - | Jan. 07 |
McGregor Grant
DFI | Director of Finance/CFO | - | 23-09-27 |
Chairman | - | 23-09-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 0.08 | -1.23% | 298,878 |
24-05-06 | 0.081 | +1.25% | 817,183 |
24-05-03 | 0.08 | 0.00% | 1,309,197 |
24-05-02 | 0.08 | 0.00% | 1,974,280 |
24-05-01 | 0.08 | -4.76% | 4,762,048 |
Delayed Quote Australian S.E., May 07, 2024 at 02:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.83% | 108M | |
+7.93% | 219B | |
+7.53% | 183B | |
+15.20% | 136B | |
+27.02% | 107B | |
-1.14% | 63.07B | |
+7.23% | 52.55B | |
+12.58% | 51.28B | |
+1.61% | 41.21B | |
+5.32% | 36.43B |
- Stock Market
- Equities
- IPD Stock